フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
NATICK, Mass., Jan. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial...
NATICK, Mass., Dec. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the pricing of a public offering of $2...
Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets...
Three models of stenting system now available for palliative treatment of malignant common bile duct strictures NATICK, Mass., Oct. 6...
NATICK, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Morgan Stanley...
NATICK, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Thomas Weisel...
NATICK, Mass. and BARCELONA, Sept. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced long-term data from the...
Results of landmark heart failure trial published by New England Journal of Medicine and presented at ESC NATICK, Mass., and BARCELONA, Spain...
NATICK, Mass., Aug. 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the schedule of the Company's major...
NATICK, Mass., July 7 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial...
NATICK, Mass., April 15 /PRNewswire-FirstCall/ -- Boston Scientific (NYSE: BSX) today announced special items that will reduce its GAAP earnings...
FT. LAUDERDALE, Fla. and HONG KONG, March 16 /PRNewswire/ -- OrbusNeich Medical, Inc. ("Orbus" or the "Company"), a designer, developer...
Dr. Keith Dawkins and Dr. Takahiro Uchida to join the Company NATICK, Mass., Oct. 26 /PRNewswire-FirstCall/ -- Boston Scientific today announced...
NEW YORK, Aug. 2 /PRNewswire/ -- S&P Equity Research Services announced today its positive view on the new Medicare medical device reimbursement...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約